Asset Details
Do you wish to reserve the book?
Liquid crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate complex for psoriasis management
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Liquid crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate complex for psoriasis management
Do you wish to request the book?
Liquid crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate complex for psoriasis management
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Liquid crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate complex for psoriasis management
2019
Overview
The current work highlighted preparation of highly penetrating liquid crystalline nanoparticulates (LCNPs) reservoir of a solubility modified berberine oleate (Brb-OL) complex for effective psoriasis management.
Brb-OL-loaded LCNPs (Brb-OL-LCNPs) were prepared using hydrotrope method.
The proposed Brb-OL-LCNPs showed a particle size of 137 ± 3.7 nm and negative ζ-potential (-38 ± -5.85 mV). Brb-OL-LCNPs showed a threefold increase in the drug accumulated within rat skin and around tenfold increase in the drug permeation compared with crude Brb.
studies revealed that topical application of Brb-OL-LCNPs hydrogel significantly alleviated psoriasis symptoms and reduced the levels of psoriatic inflammatory cytokines.
Formulating Brb-OL in the LCNPs controlled the release, retention and permeation of the drug across skin layers, which are of prime importance for psoriasis management.
Publisher
Future Medicine Ltd
